Overview
Citrulline is an amino acid. It is made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle. It is also produced from arginine as a by-product of the reaction catalyzed by NOS family. Its name is derived from citrullus, the Latin word for watermelon, from which it was first isolated.
Indication
Used for nutritional supplementation, also for treating dietary shortage or imbalance.
Associated Conditions
No associated conditions information available.
Research Report
A Comprehensive Pharmacological and Clinical Monograph on L-Citrulline (DB00155)
Executive Summary
L-Citrulline is a non-proteinogenic α-amino acid with a unique and multifaceted role in human physiology. While endogenously synthesized, its therapeutic and supplemental applications stem from a distinctive pharmacological profile, primarily its function as a highly bioavailable precursor to L-arginine. This report provides an exhaustive analysis of L-Citrulline, synthesizing its chemical properties, metabolic pathways, clinical pharmacology, therapeutic efficacy, and safety profile.
A central finding of this monograph is the "Citrulline Paradox": oral administration of L-citrulline is a more effective strategy for increasing systemic L-arginine levels than supplementing with L-arginine itself. This is due to L-citrulline's ability to bypass the extensive first-pass metabolism in the gut and liver that significantly limits L-arginine's bioavailability. This superior pharmacokinetic profile is the foundation for its clinical applications, which are primarily mediated by the subsequent enhancement of the L-arginine-nitric oxide (NO) pathway.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/05/25 | Phase 3 | Not yet recruiting | |||
2024/10/10 | Phase 2 | Recruiting | Suvankar Majumdar | ||
2024/03/15 | Phase 1 | Recruiting | |||
2024/01/19 | Phase 3 | Not yet recruiting | University Hospital, Grenoble | ||
2022/03/02 | Phase 2 | Recruiting | |||
2022/02/23 | Phase 3 | Recruiting | |||
2021/07/28 | Phase 1 | Suspended | |||
2021/04/21 | Phase 1 | Recruiting | |||
2020/09/30 | Phase 2 | Completed | |||
2019/05/16 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Perdido Key Health and Wellness Inc | 70104-128 | INTRAMUSCULAR | 1 mg in 1 mL | 11/23/2015 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
METHODICAL PRE-WORKOUT | 462072 | Medicine | A | 9/9/2024 | |
Cardio-H | 411451 | Medicine | A | 6/28/2023 | |
BergaMALE + | 462928 | Medicine | A | 9/26/2024 | |
Swisse Ultiboost Men's Potency+ | 399452 | Medicine | A | 11/15/2022 | |
LIBIDO PLUS + | 425111 | Medicine | A | 10/12/2023 | |
CardioBrain Plus 12000 GINKGO Brain Circulation & Memory Support | 473525 | Medicine | A | 12/17/2024 | |
SG Swisse Ultiboost Male Vitality | 407214 | Medicine | A | 4/3/2023 | |
HeartFlow Support Complex | 482542 | Medicine | A | 3/14/2025 | |
METHODICAL PRE-WORKOUT | 462449 | Medicine | A | 9/20/2024 | |
Wonderlab Men's Multivitamin | 482148 | Medicine | A | 3/11/2025 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.